Recruiting Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer NCT07500298 Conditions Bevacizimab, Colonic Diseases, Colorectal Neoplasms, +15 more Locations MD Anderson Cancer Center — Houston, Texas, United States View Trial Details
